{"id":847916,"date":"2025-05-07T07:04:18","date_gmt":"2025-05-07T11:04:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/"},"modified":"2025-05-07T07:04:18","modified_gmt":"2025-05-07T11:04:18","slug":"skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/","title":{"rendered":"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, May  07, 2025  (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on Thursday, May 8th at 1:30 p.m. PT\/4:30 p.m. ET to discuss its 2025 first quarter financial results. An earnings press release will be issued after the market close on May 8th.<\/p>\n<p align=\"justify\">The live webcast of the call can be accessed at the Skye <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rtGo4Dp4qbT43A3vioWxB4V6LmV98RKPQKu2mOtMFjJiKIpGmNUhSchBK3fX7rwcRAIIW7uKHnVeGr4HM4QtHVlUnvp3PFFRcVk75NLojgbc9xd1Tn0iaLW5abXB9YpijiMiemHaqElNmRos1eXnKeRlCWC1-ODMMjsQV9kSJPM=\" rel=\"nofollow\" target=\"_blank\"><u>Investor Relations<\/u><\/a> website, along with the company&#8217;s earnings press release, financial tables, and investor presentation. Please join the call 5-10 minutes prior to the scheduled start time. Following the call, a replay and transcript will be available at the same website.<\/p>\n<p align=\"justify\">\n        <strong>About Skye Bioscience <\/strong>\n      <\/p>\n<p align=\"justify\">Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye&#8217;s strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation. Skye is conducting a Phase 2 clinical trial (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DlfDu9Z2gINtsnw6aEGRRPvG7faFPx76nOJcFSsuEwboXXOdYgAyoIQOJ7U7NbQRoXMEaNKuapqWFf0gVnKWBxiPNRhC77M_969OHCIPU7l2bAizvLmx4sET9NXE13sCsT9eyHBFgmLcEf2xymdMrw==\" rel=\"nofollow\" target=\"_blank\"><u>ClinicalTrials.gov: NCT06577090<\/u><\/a>) in obesity for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1. This study is also assessing the combination of nimacimab and a GLP-1R agonist (Wegovy\u00ae). For more information, please visit: <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Fb0-_lCd895RzRSsz3cTlMa-H6eTNkZyY25r3sMYyhJMo2KLt-TC4ZFBWxVDpE8gHWhd2b9wmOyLeCnczGpRmrhMndFkbNeys8SyFmf8jL4=\" rel=\"nofollow\" target=\"_blank\">www.skyebioscience.com<\/a><\/u>. Connect with us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JU-XsTn1uv7IyC3xVg8s2kxUnBlzbGzVCWnUoCR-yeRyEtRZh6y11cBDWd-2k5hGNPc53yBzVY2esMOYIqzdDA==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ub8IxlBmEc81wgxLKvRSlDs30LGvVCqFvWb8QkayOA5j_ke14EGqjknFrkMJ1v1Ch3WsGNfe9BOjikKP7h4ITaDx3ZmqfTbKsoK-BV64SSebpI8fqI_iCL-4qHy4Uws5\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.<\/p>\n<p>\n        <strong>CONTACTS<\/strong>\n      <\/p>\n<p>Investor Relations<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aNBFZSgS31gmsArDB_YckAo0uGuvuRoOyzGzrc1PgDad1ljnAxTDF1g8ZBu7QZNFHKD2351HlJcOtFbiWsvinA-_5plSO1fxRdxP-4H-AlU=\" rel=\"nofollow\" target=\"_blank\">ir@skyebioscience.com<\/a><\/u><br \/>(858) 410-0266<\/p>\n<p>LifeSci Advisors, Mike Moyer<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=N4rbPvmBGyFnbmNZTNK3DVmDAccPE0SDp1Ar252DISj2hehFYPJIsVCMdhP_cQi6VDomCqz8oZkjCmy_kFk4580QOasrrLOLEK8Im17v-DbnkdqNjVVHqxumYA9tOX-Y\" rel=\"nofollow\" target=\"_blank\">mmoyer@lifesciadvisors.com<\/a><\/u><br \/>(617) 308-4306<\/p>\n<p>Media Inquiries<br \/>LifeSci Communications, Michael Fitzhugh<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9fTJaDEVQjPpmFgR28xdfaG1GmIePyrR4oE_YyC7oTC6TBGI4OOT7eZKr4aorI7KTv1lwhFAlvgMyoltnk8wTUXHu6bZqaLuN6WakwLlo5E_waHq9gheOM2nyv2_-sG7\" rel=\"nofollow\" target=\"_blank\">mfitzhugh@lifescicomms.com<\/a><\/u><br \/>(628) 234-3889<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NjEwMCM2OTI1OTM4IzUwMDEyMDM5Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MjAwNmEwZWEtMTFmMC00OWE1LTg0NDMtNDYwMzFhM2FiNmQ0LTUwMDEyMDM5Ny0yMDI1LTA1LTA3LWVu\/tiny\/Skye-Bioscience-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on Thursday, May 8th at 1:30 p.m. PT\/4:30 p.m. ET to discuss its 2025 first quarter financial results. An earnings press release will be issued after the market close on May 8th. The live webcast of the call can be accessed at the Skye Investor Relations website, along with the company&#8217;s earnings press release, financial tables, and investor presentation. Please join the call 5-10 minutes prior to the scheduled start time. Following the call, a replay and transcript will be available at the same &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-847916","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on Thursday, May 8th at 1:30 p.m. PT\/4:30 p.m. ET to discuss its 2025 first quarter financial results. An earnings press release will be issued after the market close on May 8th. The live webcast of the call can be accessed at the Skye Investor Relations website, along with the company&#8217;s earnings press release, financial tables, and investor presentation. Please join the call 5-10 minutes prior to the scheduled start time. Following the call, a replay and transcript will be available at the same &hellip; Continue reading &quot;Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-07T11:04:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NjEwMCM2OTI1OTM4IzUwMDEyMDM5Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025\",\"datePublished\":\"2025-05-07T11:04:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/\"},\"wordCount\":254,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NjEwMCM2OTI1OTM4IzUwMDEyMDM5Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/\",\"name\":\"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NjEwMCM2OTI1OTM4IzUwMDEyMDM5Nw==\",\"datePublished\":\"2025-05-07T11:04:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NjEwMCM2OTI1OTM4IzUwMDEyMDM5Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NjEwMCM2OTI1OTM4IzUwMDEyMDM5Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/","og_locale":"en_US","og_type":"article","og_title":"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025 - Market Newsdesk","og_description":"SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) &#8212; Skye Bioscience, Inc. (Nasdaq: SKYE) (\u201cSkye\u201d), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on Thursday, May 8th at 1:30 p.m. PT\/4:30 p.m. ET to discuss its 2025 first quarter financial results. An earnings press release will be issued after the market close on May 8th. The live webcast of the call can be accessed at the Skye Investor Relations website, along with the company&#8217;s earnings press release, financial tables, and investor presentation. Please join the call 5-10 minutes prior to the scheduled start time. Following the call, a replay and transcript will be available at the same &hellip; Continue reading \"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-07T11:04:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NjEwMCM2OTI1OTM4IzUwMDEyMDM5Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025","datePublished":"2025-05-07T11:04:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/"},"wordCount":254,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NjEwMCM2OTI1OTM4IzUwMDEyMDM5Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/","name":"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NjEwMCM2OTI1OTM4IzUwMDEyMDM5Nw==","datePublished":"2025-05-07T11:04:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NjEwMCM2OTI1OTM4IzUwMDEyMDM5Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NjEwMCM2OTI1OTM4IzUwMDEyMDM5Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-announce-2025-first-quarter-financial-results-on-may-8th-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/847916","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=847916"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/847916\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=847916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=847916"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=847916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}